Invention Grant
- Patent Title: Noxa-derived, cell death-inducing peptide eMTD
-
Application No.: US16774423Application Date: 2020-01-28
-
Publication No.: US11248024B2Publication Date: 2022-02-15
- Inventor: Tae-Hyoung Kim , Junghee Park , Ji-Hye Han , Seung-Hyun Myung
- Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY
- Applicant Address: KR Gwangju
- Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY
- Current Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY
- Current Assignee Address: KR Gwangju
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: KR10-2019-0010678 20190128
- Main IPC: A61K38/10
- IPC: A61K38/10 ; C07K7/08 ; A61P35/00 ; A61K47/62 ; A61K38/00

Abstract:
Disclosed herein is a cell death-inducing peptide that rapidly acts. The peptide is derived from Noxa protein and comprises 16 amino acid residues including MTD. The peptide is designated extended MTD (eMTD) because it contains the 10-mer MTD. eMTD rapidly exhibits potent necrotic cell death in various cell lines and, as such, can be applied to the treatment of various diseases including cancer when used in conjugation with peptides or materials for targeting specific cells.
Public/Granted literature
- US20200239521A1 NOXA-DERIVED, CELL DEATH-INDUCING PEPTIDE eMTD Public/Granted day:2020-07-30
Information query
IPC分类: